Literature DB >> 17708365

Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer.

Tatjana Ivkovic-Kapicl1, Slavica Knezevic-Usaj, Dragana Djilas-Ivanovic, Milana Panjkovic.   

Abstract

BACKGROUND: The objective of our study was to investigate the association between Her-2/neu status and other clinicopathological characteristics of ductal breast carcinoma. PATIENTS AND METHODS: A total of 120 cases of breast carcinoma were included in this study. The immunohistochemical staining for HER-2/neu, hormone receptors, p53 and Ki-67 were evaluated.
RESULTS: HER-2/neu protein overexpression was present in 4 out of 63 T1 lesions, in 13 out of 44 T2 lesions, in 3 out of 7 T3 lesions, and in 3 out of 6 T4 lesions. Protein overexpression was found in 10 out of 21 grade III tumors and 13 out of 72 grade II tumors. Overexpression was not detected in grade I tumors. Of the 23 Her-2/Neu-positive cases, ER- and PR-negative status was detected in 61% and 69%, respectively. Her-2 protein overexpression was seen in 23 out of 93 high Ki-67 tumors, whereas overexpression was not detected in low Ki-67 cases.
CONCLUSION: Statistically significant correlation was found between HER-2/neu protein overexpression and large tumour size, high histological grade, ER and PR negativity, and high Ki-67 proliferative index.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17708365

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  9 in total

1.  Breast Cancer in Turkey: Clinical and Histopathological Characteristics (Analysis of 13.240 Patients).

Authors:  Vahit Özmen
Journal:  J Breast Health       Date:  2014-04-01

2.  Sentinel Lymph Node Biopsy After Initial Lumpectomy (SNAIL Study)-a Prospective Validation Study.

Authors:  Sanjit Kumar Agrawal; Lalit Bansawal; Indu Arun; Soumtira Shankar Datta; Sanjoy Chatterjee; Rosina Ahmed
Journal:  Indian J Surg Oncol       Date:  2018-12-18

3.  Correlation of ER, PR and HER-2/Neu with other Prognostic Factors in Infiltrating Ductal Carcinoma of Breast.

Authors:  Sepideh Siadati; Majid Sharbatdaran; Novin Nikbakhsh; Naser Ghaemian
Journal:  Iran J Pathol       Date:  2015

4.  Study of Metastasis in Lymphnode Biopsies with Special Reference to Immunohistochemistry (IHC) in Metastatic Breast Carcinoma.

Authors:  Syed Ali Baqher Hussaini; Sainath K Andola; Anita Mahanta
Journal:  J Clin Diagn Res       Date:  2015-03-01

5.  Study of hormone receptors and epidermal growth factor expression in invasive breast cancers in a cohort of Western India.

Authors:  Hardik Dodiya; Amit Patel; Dipal Patel; Ashish Kaushal; D G Vijay
Journal:  Indian J Clin Biochem       Date:  2013-01-03

6.  Exposure to depleted uranium does not alter the co-expression of HER-2/neu and p53 in breast cancer patients.

Authors:  Mais M Al-Mumen; Asad A Al-Janabi; Alaa S Jumaa; Kaswer M Al-Toriahi; Akeel A Yasseen
Journal:  BMC Res Notes       Date:  2011-03-29

7.  Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.

Authors:  Zhen-Jun Tong; Ning-Yao Shi; Zhi-Ji Zhang; Xiao-Dong Yuan; Xiao-Ming Hong
Journal:  Biosci Rep       Date:  2017-08-02       Impact factor: 3.840

8.  Evaluation of Immunohistochemistry-Equivocal (2+) HER2 Gene Status in Invasive Breast Cancer by Silver DNA in Situ Hybridization (SISH) and its Association with Clinicopathological Variables.

Authors:  Zaidoon A Musa; Ban J Qasim; A Wahab A K Al Shaikhly
Journal:  Iran J Pathol       Date:  2016-08-30

9.  Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer.

Authors:  Gulijire Tailaiti; Gulanbaier Maimaiti; Youlituzi Aikeremu; Batuer Tuerdi
Journal:  Int J Gen Med       Date:  2021-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.